Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells

Özlem Özdemir, Lisa Marinelli, Ivana Cacciatore, Michele Ciulla, Bugrahan Emsen*, Antonio Di Stefano, Adil Mardinoglu, Hasan Turkez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Several epidemiologic, clinical and experimental reports indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) could have a potential as anticancer agents. The aim of this study was the evaluation of cytotoxic potential in human glioblastoma cells of novel synthesized NSAID derivatives, obtained by linking, through a spacer, α-lipoic acid (ALA) to anti-inflammatory drugs, such as naproxen (AL-3, 11 and 17), flurbiprofen (AL-6, 13 and 19) and ibuprofen (AL-9, 15 and 21). The effects on the level of gene expression were also determined using quantitative real-time polymerase chain reaction (qRT-PCR) analysis. According to our results, NSAID derivatives exhibited concentration dependent cytotoxic effects on U87-MG cell line when compared with the control group. Moreover, treatment of the most active compounds (AL-3, AL-6 and AL-9) caused upregulation of tumor suppressor gene PTEN and downregulation of some oncogenes such as AKT1, RAF1 and EGFR. In conclusion, our results revealed that AL-3, AL-6 and AL-9 could be suitable candidates for further investigation to develop new pharmacological strategies for the prevention of cancer.

Original languageEnglish
JournalZeitschrift fur Naturforschung - Section C Journal of Biosciences
DOIs
Publication statusAccepted/In press - 2020

Keywords

  • AKT1
  • antiproliferative action
  • glioblastoma
  • NSAIDs
  • PTEN

Fingerprint

Dive into the research topics of 'Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells'. Together they form a unique fingerprint.

Cite this